دورية أكاديمية

Tolerance of benznidazole in a United States Chagas Disease clinic.

التفاصيل البيبلوغرافية
العنوان: Tolerance of benznidazole in a United States Chagas Disease clinic.
المؤلفون: Miller DA; Los Angeles Biomedical Research Division of Infectious Diseases, Harbor-UCLA Medical Center, Torrance., Hernandez S; Center of Excellence for Chagas Disease, Olive View-UCLA Medical Center, Sylmar, California., Rodriguez De Armas L; Center of Excellence for Chagas Disease, Olive View-UCLA Medical Center, Sylmar, California., Eells SJ; Los Angeles Biomedical Research Division of Infectious Diseases, Harbor-UCLA Medical Center, Torrance., Traina MM; Center of Excellence for Chagas Disease, Olive View-UCLA Medical Center, Sylmar, California., Miller LG; Los Angeles Biomedical Research Division of Infectious Diseases, Harbor-UCLA Medical Center, Torrance., Meymandi SK; Center of Excellence for Chagas Disease, Olive View-UCLA Medical Center, Sylmar, California.
المصدر: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2015 Apr 15; Vol. 60 (8), pp. 1237-40. Date of Electronic Publication: 2015 Jan 18.
نوع المنشور: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE
أسماء مطبوعة: Publication: Jan. 2011- : Oxford : Oxford University Press
Original Publication: Chicago, IL : The University of Chicago Press, c1992-
مواضيع طبية MeSH: Chagas Disease/*drug therapy , Drug-Related Side Effects and Adverse Reactions/*epidemiology , Nitroimidazoles/*adverse effects , Trypanocidal Agents/*adverse effects, Adolescent ; Adult ; Aged ; Angioedema/chemically induced ; Angioedema/epidemiology ; Female ; Humans ; Male ; Middle Aged ; Nitroimidazoles/therapeutic use ; Peripheral Nervous System Diseases/chemically induced ; Peripheral Nervous System Diseases/epidemiology ; Retrospective Studies ; Trypanocidal Agents/therapeutic use ; United States ; Young Adult
مستخلص: The US-based Center of Excellence for Chagas Disease performed an observational study on the safety and tolerance of benznidazole 5 mg/kg/day for 60 days in 30 adults with chronic Chagas disease. The side-effect profile was suboptimal, including 5 cases of debilitating neuropathy and an unusually high angioedema rate.
(© The Author 2015. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.)
التعليقات: Comment in: Clin Infect Dis. 2015 Jun 15;60(12):1873-5. (PMID: 25805302)
Comment in: Clin Infect Dis. 2015 Jun 15;60(12):1875-6. (PMID: 25805304)
Comment in: Clin Infect Dis. 2016 Apr 15;62(8):1052. (PMID: 26769725)
فهرسة مساهمة: Keywords: Chagas disease; United States; benznidazole; drug tolerance; trypanosomiasis
المشرفين على المادة: 0 (Nitroimidazoles)
0 (Trypanocidal Agents)
YC42NRJ1ZD (benzonidazole)
تواريخ الأحداث: Date Created: 20150121 Date Completed: 20151214 Latest Revision: 20220321
رمز التحديث: 20240628
DOI: 10.1093/cid/civ005
PMID: 25601454
قاعدة البيانات: MEDLINE
الوصف
تدمد:1537-6591
DOI:10.1093/cid/civ005